Skip to main content

A 50-years-old female presented with bilateral leg swelling, chest pain & shortness of breath, having Hb 2.9 gm/dl drammatically improved only with 1.5 months Iron supplements

Disclaimer:-

This is a HIPAA de-identified open-online-patient-record with initial information in patient's voice, posted here February 2017 after collecting informed patient consent (form downloadable Click Here)  by BMJ Elective Student. 

Journey of a patient from getting typical symptoms of "Anemia with Hb 2.9 gm/dl" to " Hb 11.1 gm/dl with improvement in symptoms" within one and half months:

Story before 1.5 months:

Patient was presented to OPD with the complain of chest pain, shortness of breath and bilateral leg swelling with no history of blood loss. Patient was reasonably well 7 days prior to presentation. ↧

                                                 

Lab investigations were ordered that turned out to have very low HB level (2.9 gm/dl) [All the reports are attached] 



                           ↧

Patient was diagnosed with Iron deficiency anemia and prescribed with ferrous fumarate 150mg (OD) for 15 days and no blood transfusions were advised.

After 15 Days:  

Patient came to OPD for the follow up and tests were repeated which turned out that patients HB level is increased upto 5.1 gm/dl. [All the reports are attached]  

                           ↧







                          
   
                            ↧

This time patient was advised to continue the same Iron supplements for 3 weeks more.

1 Month Later:


Patient again came for the follow up and tests were repeated which showed that patients HB level has increased now to 11.1 gm/dl. 





Now, the question remains to answer:

1. How dramatic it is to see Hb level from 2.9  - 5.5 - 11.1 (gm/dl) within 1.5months of iron supplements without blood transfusion?

2. Could it be more better with blood transfusion?



Comments

Popular posts from this blog

55 years Old male with Bipolar affected disorder moving from depression to Manic to depression phase

Disclaimer:- This is a HIPAA de-identified open-online-patient-record with initial information in patient's voice, posted here December 2017 after collecting informed patient consent (form downloadable Click Here) This is a case of a 55 years old, diabetic, hypertensive patient who was diagnosed with Bipolar affected disorder since 1995. In 1995 due to financial loss he was attacked by this condition. He was seen by Dr. D. K Agarwala and diagnosed as BPAD-Depression phase and treated with lithium, sodium valporate, propranolol, Zeptol cr, Nitrosum - S.  With the treatment he was reasonably well but every 6 months of interval he appeared to have some disturbance like didn't want to talk to anybody, forgot to smile etc. They went to the doctor and treated accordingly and was continuing the treatment.  In the year of 2013, August he was diagnosed with BPAD-severe depression phase but, he was not responding well to the medications and then they went to NIMHANS for

Consent Forms

Hindi BMJ Consent form   Bengali BMJ Consent form English BMJ Consent form   Telegu BMJ Consent Form Telegu BMJ Consent Form   UDHC Consent Form                

drugs to avoid or use in terms of their pregnancy category

The optimal AEDs therapy of women with epilepsy who are of childbearing age is unclear because of a lack of conclusive data on the comparative teratogenicity of different antiseizure drugs and no antiepileptic drug has proven safe in pregnancy in terms of teratogenesis. Data on the comparative efficacy of various antiseizure drugs for controlling seizures during pregnancy are also quite limited, and there are no randomized trials in this setting. Treatment must be individualized for all patients. Women with epilepsy are classified as high risk during pregnancy and as there are no clear data indicating that any drug is without risk in pregnancy therefore, the antiseizure drug regimen should be optimized six months prior to planned conception.  Choice of antiepileptic drugs in women of childbearing age and  pregnant women with epilepsy:  1. T he antiseizure drug that stops seizures in a given patient is the one that should be used with an exception of valproate. 2.